Koyfin Home > Directory > Health Care > Adamas Pharma > EV / EBITDA (ntm)

Adamas Pharma EV / EBITDA (ntm) Chart (ADMS)

Adamas Pharma annual/quarterly EV / EBITDA (ntm) from 2014 to 2014. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Adamas Pharma EV / EBITDA (ntm) for the quarter ending May 05, 2014 was 65.41 a 42.74% increase of 27.96 year over year
  • Adamas Pharma EV / EBITDA (ntm) for the last 12 months ending May 05, 2014 was 65.41 a 42.74% increase of 27.96 year over year
  • Adamas Pharma Annual EV / EBITDA (ntm) for 2014 was 65.41 a 43.63% increase of 28.54 from 2013
  • Adamas Pharma Annual EV / EBITDA (ntm) for 2014 was 36.87 a -0.57% decrease of -0.21 from 2013
  • Adamas Pharma Annual EV / EBITDA (ntm) for 2014 was 37.08 a -1.00% decrease of -0.37 from 2013
Other Valuation Metrics:
  • Adamas Pharma Market Cap for the quarter ending March 03, 2018 was $641m a 38.96% increase of 250m year over year
  • Adamas Pharma Price / Book for the quarter ending March 03, 2018 was 8.43 a 61.32% increase of 5.17 year over year
  • Adamas Pharma Enterprise Value for the quarter ending March 03, 2018 was $570m a 51.05% increase of 291m year over year
View Chart On Koyfin

Quarterly ADMS EV / EBITDA (ntm) Data

05/201465.41
05/201436.87
05/201437.08
05/201437.45
05/201439.01
05/201439.12
05/201439.12

Annual ADMS EV / EBITDA (ntm) Data

201465.41
201436.87
201437.08
201437.45
201439.01
201439.12
201439.12